Canopy Partners’s Advantest Corp ATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$784K Buy
3,766
+1
+0% +$208 0.24% 82
2026
Q1
$511K Sell
3,765
-11
-0.3% -$1.49K 0.18% 108
2025
Q4
$477K Sell
3,776
-172
-4% -$21.7K 0.16% 117
2025
Q3
$397K Buy
3,948
+64
+2% +$6.43K 0.13% 133
2025
Q2
$287K Buy
+3,884
New +$287K 0.11% 161
2025
Q1
Sell
-3,991
Closed -$227K 224
2024
Q4
$227K Buy
+3,991
New +$227K 0.09% 170

Other funds holding ATE

Canopy Partners's ATE Position: Q2 2026 in Review

Canopy Partners increased its Advantest Corp (ATE) stake by 0.03% in Q2 2026, buying an estimated $208 and bringing the position to 3,766 shares worth $784K. The position accounts for 0.24% of the portfolio, ranked #82.

Canopy Partners first reported a position in ATE in Q4 2024 and has held it in 6 quarters since. 11 funds tracked by Wall St. Rank hold ATE as of Q2 2026.

  • Canopy Partners held 3,766 shares of Advantest Corp worth $784K as of Q2 2026.
  • Canopy Partners bought 1 Advantest Corp share in Q2 2026, an estimated $208.
  • Advantest Corp made up 0.24% of Canopy Partners's portfolio in Q2 2026, its #82 holding.
  • Canopy Partners first reported a position in Advantest Corp in Q4 2024 and has held it in 6 quarters since.
  • 11 funds tracked by Wall St. Rank held Advantest Corp as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.